Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach.

Détails

Ressource 1Télécharger: 35625256_BIB_E09CDBB50739.pdf (669.41 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_E09CDBB50739
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach.
Périodique
Antibiotics
Auteur⸱e⸱s
van den Bogaart L., Manuel O.
ISSN
2079-6382 (Print)
ISSN-L
2079-6382
Statut éditorial
Publié
Date de publication
02/05/2022
Peer-reviewed
Oui
Volume
11
Numéro
5
Pages
612
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: epublish
Résumé
Lung transplant recipients are at higher risk to develop infectious diseases due to multi-drug resistant pathogens, which often chronically colonize the respiratory tract before transplantation. The emergence of these difficult-to-treat infections is a therapeutic challenge, and it may represent a contraindication to lung transplantation. New antibiotic options are currently available, but data on their efficacy and safety in the transplant population are limited, and clinical evidence for choosing the most appropriate antibiotic therapy is often lacking. In this review, we provide a summary of the best evidence available in terms of choice of antibiotic and duration of therapy for MDR/XDR P. aeruginosa, Burkholderia cepacia complex, Mycobacterium abscessus complex and Nocardia spp. infections in lung transplant candidates and recipients.
Mots-clé
Burkholderia cepacia complex, MDR Pseudomonas aeruginosa, Mycobacterium abscessus complex, lung transplant, nocardiosis
Pubmed
Web of science
Open Access
Oui
Création de la notice
10/06/2022 16:47
Dernière modification de la notice
23/01/2024 8:35
Données d'usage